Annual report
3937.TEDINET S100OFUN
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 155
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥4.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥4.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥920m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥877m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥716m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥591m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥355m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥877m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥832m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥624m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥533m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥369m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥213m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥832m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥624m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥5.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥3.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.5bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.8bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.9bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.2bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥874m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥922m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥499m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥568m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥295m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥203m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥61m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥69m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥207m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥81m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥152m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥76m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥96m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥59m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥51m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥70.38 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.25 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.17 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.57 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.08 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥68.49 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51.75 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.81 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.43 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.61 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥322.44 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥249.28 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥190.24 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥147.18 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥114.92 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 67.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.3% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 24.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.2% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 27.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.7% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.7% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 947 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 935 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,021 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 955 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 881 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥35m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥148m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥233m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥88m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥59m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥62m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥216m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥86m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥384m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥200m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥728,000 | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥142m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥70m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥1.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥308m | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥223m | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥578m | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥482m | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥32.45 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.11 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.06 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.52 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.3 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥31.57 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.63 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.08 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥5.94 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥9 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥173.83 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥148.07 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥130.97 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥134.95 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥122.59 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 87.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.5% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.2% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 11,834,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,802,880 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,657,120 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,483,360 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,257,760 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 58 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 59 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 68 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 59 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 59 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 75
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥720,000 |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥76m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥76m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥983m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥309m |
| Global Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥251m |
| Global Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥96m |
| Global Businessreportable segment | employees | at 2022-03-31 | 884 pure |
| Global Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.3bn |
| Global Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥76m |
| Global Businessreportable segment | segment assets | at 2022-03-31 | ¥2.4bn |
| Global Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥496m |
| Medical Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥30m |
| Medical Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Medical Businessreportable segment | employees | at 2022-03-31 | 50 pure |
| Medical Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Medical Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Medical Businessreportable segment | segment assets | at 2022-03-31 | ¥2.3bn |
| Medical Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥847m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥281m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| —segment total | employees | at 2022-03-31 | 934 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥76m |
| —segment total | segment assets | at 2022-03-31 | ¥4.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥281m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥76m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Otherother segments | revenue | 2020-04-01 → 2021-03-31 | ¥2m |
| Otherother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥2m |
| Otherother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥800,000 |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥731,000 |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥58m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥58m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥622m |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥308m |
| Global Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥85m |
| Global Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥114m |
| Global Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Global Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Global Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥51m |
| Global Businessreportable segment | segment assets | at 2021-03-31 | ¥1.9bn |
| Global Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥493m |
| Medical Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥279,000 |
| Medical Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥33m |
| Medical Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.4bn |
| Medical Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.4bn |
| Medical Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥7m |
| Medical Businessreportable segment | segment assets | at 2021-03-31 | ¥1.9bn |
| Medical Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥734m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥85m |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥147m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥4.3bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥4.2bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥58m |
| —segment total | segment assets | at 2021-03-31 | ¥3.8bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥85m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥4.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥58m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Global Businessreportable segment | employees | at 2022-03-31 | 45 pure |
| —segment total | employees | at 2022-03-31 | 45 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,464
| Item | Context | Value | Unit |
|---|---|---|---|
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Current period end date | FilingDateInstant | 2022-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2020-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2021-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所市場第一部（事業年度末現在）プライム市場（提出日現在） | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)青木 正之 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)兵庫県西宮市 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２丁目11番３号 | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)JP MORGAN CHASE BANK 385839（常任代理人 株式会社みずほ銀行決済営業部） | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)AKIRA KONISHI（常任代理人 株式会社Ubicomホールディングス） | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)MUNTINLUPACITY METRO MANILA PHILIPPINES（東京都文京区小石川２丁目23番11号） | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)UBS証券株式会社 | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町１丁目２番１号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |